title: Doubling Down on mTOR Inhibition: Harnessing ZEBRA for Insights.
authors.affiliation: Department of Medical Oncology, National Cancer Centre Singapore, Singapore.
authors.forename: Jason Yongsheng
authors.initials: JY
authors.lastname: Chan
authors.affiliation: Institute of Bioengineering and Nanotechnology, Singapore.
authors.forename: Yukti
authors.initials: Y
authors.lastname: Choudhury
authors.affiliation: Department of Medical Oncology, National Cancer Centre Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore. Electronic address: mhtan@ibn.a-star.edu.sg.
authors.forename: Min-Han
authors.initials: MH
authors.lastname: Tan
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D018397:Equidae; D006801:Humans; D047428:Protein Kinase Inhibitors; D015398:Signal Transduction; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism
chemical_list: D047428:Protein Kinase Inhibitors; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus